Email ID
Sign me in automatically next time
India rejects Abbott's patent application for Kaletra

India has rejected Abbott's patent application for its antiretroviral drug, Kaletra/Aluvia (lopinavir plus ritonavir), following opposition from the US-based non-profit group, Initiative for...
04 January 2011
Anju Ghangurde

Please Login to read the full article.
04 April 2016
Stockholm, Sweden
06 April 2016
Hamburg, Germany
JOB OF THE WEEK Promote your job vacancy
© 2016 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36